191 related articles for article (PubMed ID: 21791142)
1. Marine n-3 fatty acids, atrial fibrillation and QT interval in haemodialysis patients.
Kirkegaard E; Svensson M; Strandhave C; Schmidt EB; Jørgensen KA; Christensen JH
Br J Nutr; 2012 Mar; 107(6):903-9. PubMed ID: 21791142
[TBL] [Abstract][Full Text] [Related]
2. The content of docosahexaenoic acid in serum phospholipid is inversely correlated with plasma homocysteine levels in patients with end-stage renal disease.
Rasmussen LE; Svensson M; Jørgensen KA; Schmidt EB; Christensen JH
Nutr Res; 2010 Aug; 30(8):535-40. PubMed ID: 20851307
[TBL] [Abstract][Full Text] [Related]
3. Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients--a pilot study.
Saifullah A; Watkins BA; Saha C; Li Y; Moe SM; Friedman AN
Nephrol Dial Transplant; 2007 Dec; 22(12):3561-7. PubMed ID: 17623719
[TBL] [Abstract][Full Text] [Related]
4. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.
Svensson M; Schmidt EB; Jørgensen KA; Christensen JH
Nephrol Dial Transplant; 2008 Sep; 23(9):2918-24. PubMed ID: 18436564
[TBL] [Abstract][Full Text] [Related]
5. Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial.
Saravanan P; Bridgewater B; West AL; O'Neill SC; Calder PC; Davidson NC
Circ Arrhythm Electrophysiol; 2010 Feb; 3(1):46-53. PubMed ID: 20042769
[TBL] [Abstract][Full Text] [Related]
6. Omega-3 fatty acid supplementation and total homocysteine levels in end-stage renal disease patients.
Beavers KM; Beavers DP; Bowden RG; Wilson RL; Gentile M
Nephrology (Carlton); 2008 Jun; 13(4):284-8. PubMed ID: 18331436
[TBL] [Abstract][Full Text] [Related]
7. Marine n-3 polyunsaturated fatty acids in patients with end-stage renal failure and in subjects without kidney disease: a comparative study.
Madsen T; Christensen JH; Svensson M; Witt PM; Toft E; Schmidt EB
J Ren Nutr; 2011 Mar; 21(2):169-75. PubMed ID: 20833075
[TBL] [Abstract][Full Text] [Related]
8. Does treatment with n-3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery?
Heidarsdottir R; Arnar DO; Skuladottir GV; Torfason B; Edvardsson V; Gottskalksson G; Palsson R; Indridason OS
Europace; 2010 Mar; 12(3):356-63. PubMed ID: 20061328
[TBL] [Abstract][Full Text] [Related]
9. n-3 fatty acids and the risk of sudden cardiac death. Emphasis on heart rate variability.
Christensen JH
Dan Med Bull; 2003 Nov; 50(4):347-67. PubMed ID: 14694851
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of prescription omega-3-acid ethyl esters for the prevention of recurrent symptomatic atrial fibrillation: a prospective study.
Pratt CM; Reiffel JA; Ellenbogen KA; Naccarelli GV; Kowey PR
Am Heart J; 2009 Aug; 158(2):163-169.e1-3. PubMed ID: 19619690
[TBL] [Abstract][Full Text] [Related]
11. A case series of chronic haemodialysis patients: mortality, sudden death, and QT interval.
Genovesi S; Rossi E; Nava M; Riva H; De Franceschi S; Fabbrini P; Viganò MR; Pieruzzi F; Stella A; Valsecchi MG; Stramba-Badiale M
Europace; 2013 Jul; 15(7):1025-33. PubMed ID: 23284142
[TBL] [Abstract][Full Text] [Related]
12. The effect of n-3 fatty acids on C-reactive protein levels in patients with chronic renal failure.
Madsen T; Schmidt EB; Christensen JH
J Ren Nutr; 2007 Jul; 17(4):258-63. PubMed ID: 17586424
[TBL] [Abstract][Full Text] [Related]
13. Frequency and prognostic significance of QT prolongation in chronic renal failure patients.
Voiculescu M; Ionescu C; Ismail G
Rom J Intern Med; 2006; 44(4):407-17. PubMed ID: 18386617
[TBL] [Abstract][Full Text] [Related]
14. A randomized clinical trial on n-3 polyunsaturated fatty acids supplementation and all-cause mortality in elderly men at high cardiovascular risk.
Einvik G; Klemsdal TO; Sandvik L; Hjerkinn EM
Eur J Cardiovasc Prev Rehabil; 2010 Oct; 17(5):588-92. PubMed ID: 20389249
[TBL] [Abstract][Full Text] [Related]
15. A U-shaped association between consumption of marine n-3 fatty acids and development of atrial fibrillation/atrial flutter-a Danish cohort study.
Rix TA; Joensen AM; Riahi S; Lundbye-Christensen S; Tjønneland A; Schmidt EB; Overvad K
Europace; 2014 Nov; 16(11):1554-61. PubMed ID: 24574493
[TBL] [Abstract][Full Text] [Related]
16. Atrial fibrillation in chronic hemodialysis patients: prevalence, types, predictors, and treatment practices in Greece.
Tsagalis G; Bakirtzi N; Manios E; Chouliaras I; Papagiannidou P; Stamellou E; Akrivos T; Makris F; Psimenou E; Koutroubas G; Xinos K; Vemmos K
Artif Organs; 2011 Oct; 35(10):916-22. PubMed ID: 21615429
[TBL] [Abstract][Full Text] [Related]
17. Effect of fish oil (n-3 polyunsaturated fatty acids) on plasma lipids, lipoproteins and inflammatory markers in HIV-infected patients treated with antiretroviral therapy: a randomized, double-blind, placebo-controlled study.
Thusgaard M; Christensen JH; Mørn B; Andersen TS; Vige R; Arildsen H; Schmidt EB; Nielsen H
Scand J Infect Dis; 2009; 41(10):760-6. PubMed ID: 19685375
[TBL] [Abstract][Full Text] [Related]
18. Marine n-3 PUFA, heart rate variability and ventricular arrhythmias in patients on chronic dialysis: a cross-sectional study.
Rantanen JM; Schmidt EB; Riahi S; Lundbye-Christensen S; Christensen JH
Br J Nutr; 2018 Aug; 120(3):317-325. PubMed ID: 29779501
[TBL] [Abstract][Full Text] [Related]
19. n-3 polyunsaturated fatty acids and adiponectin in patients with end-stage renal disease.
Harving F; Svensson M; Flyvbjerg A; Schmidt EB; Jørgensen KA; Eriksen HH; Christensen JH
Clin Nephrol; 2015 May; 83(5):279-85. PubMed ID: 25816805
[TBL] [Abstract][Full Text] [Related]
20. Effects of Marine
Rantanen JM; Riahi S; Johansen MB; Schmidt EB; Christensen JH
Nutrients; 2018 Sep; 10(9):. PubMed ID: 30227610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
